Steven Levine, PhD

Sr. Director - Virtual Human Modeling | Dassault Systèmes

Steven Levine, PhD is the Sr. Director of Virtual Human Modeling at Dassault Systèmes. Dr. Levine has more than 30 years of experience in the development of computational science and engineering software. He is Founder and Executive Director of the Living Heart Project. Prior to his current role, he was Chief Strategy Officer for SIMULIA, the simulation brand within Dassault Systèmes. Dr. Levine was elected into the College of Fellows in the American Institute for Medical and Biological Engineering (AIMBE) in 2017 and holds a PhD in Materials Science from Rutgers University. He began his career in health tech at Accelrys, where he led Corporate Development prior to its acquisition by Dassault Systèmes in 2014.

All Sessions by Steven Levine, PhD

  • October 18, 2023


  • 2:45 PM  - 3:30 PM
    Join industry and clinical experts as they discuss the transformative potential of computer-based modeling and simulation in clinical trials. This session will explore how virtual human models can predict clinical outcomes, addressing current limitations in clinical development. Discover the applications of ‘In Silico’ clinical trials (ISCT) and the cutting-edge combination of AI methods with computational modeling and simulation to create entire patient cohorts, including synthetic (external) control arms. Through this strategy, the panelists will demonstrate how virtual populations can enhance the trial design and streamline the evaluation of new therapies. Additionally, the panel will discuss collaborative efforts with FDA to develop a playbook for ‘enriching’ clinical trials with frameworks to help accelerate advancements in the field. Attendees of this session will gain a comprehensive understanding of the transformative potential of computer-based modeling and simulation in predicting clinical outcomes. They will leave with insights into the latest advancements shaping the future of clinical trials while mitigating risks and costs, accelerating product approval timelines, and ultimately achieving better patient outcomes.
    DeviceTalks
    Where
    Theater




Share

Steven Levine, PhD